Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art Review

M Pahuja, A Johnson, R Kabir, S Bhogal… - Journal of the American …, 2022 - jacc.org
The use of mechanical circulatory support devices in cardiovascular practice has risen
exponentially over the past decade. These devices are currently used for hemodynamic …

[HTML][HTML] The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety

NK Kapur, EH Whitehead, KL Thayer, M Pahuja - F1000Research, 2020 - ncbi.nlm.nih.gov
Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock
(CS) despite a lack of high-quality clinical evidence to guide their use. Multiple devices exist …

Off-Hours versus regular-hours implantation of peripheral venoarterial extracorporeal membrane oxygenation in patients with cardiogenic shock

R Gómez-Sánchez, J García-Carreño… - Journal of Clinical …, 2023 - mdpi.com
Background. The “weekend effect” has been associated with worse clinical outcomes. Our
aim was to compare off-hours vs. regular-hours peripheral venoarterial extracorporeal …

Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain

P Gelosa, L Castiglioni, J Rzemieniec… - Journal of Molecular …, 2022 - Springer
Myocardial infarction (MI) is the leading cause of death among ischemic heart diseases and
is associated with several long-term cardiovascular complications, such as angina, re …

Review of pathophysiology of cardiogenic shock and escalation of mechanical circulatory support devices

M Pahuja, C Yerasi, PH Lam, H Hashim… - Current Cardiology …, 2023 - Springer
Abstract Purpose of Review Cardiogenic shock (CS) is a complex clinical entity that
continues to carry a high risk of mortality. The landscape of CS management has changed …

Complications from percutaneous-left ventricular assist devices versus intra-aortic balloon pump in acute myocardial infarction-cardiogenic shock

S Vallabhajosyula, AV Subramaniam, DH Murphree Jr… - PloS one, 2020 - journals.plos.org
Background There are limited data on the complications with a percutaneous left ventricular
assist device (pLVAD) vs. intra-aortic balloon pump (IABP) in acute myocardial infarction …

Percutaneous coronary intervention with Impella support with and without intra-aortic balloon in cardiogenic shock patients

R Bhuiyan, T Bimal, J Fishbein, P Gandotra… - Cardiovascular …, 2023 - Elsevier
Objective To assess the clinical characteristics and in-hospital bleeding complications and
major adverse cardiac and cerebrovascular events (MACCE) associated with the use of …

[HTML][HTML] The multicenter collaborative to enhance biologic understanding, quality, and outcomes in cardiogenic shock (VANQUISH shock): rationale and design

BN Tehrani, SG Drakos, F Billia, WB Batchelor… - Canadian Journal of …, 2022 - Elsevier
Background Despite efforts to advance therapies in cardiogenic shock (CS), outcomes
remain poor. This is likely due to several factors, including major gaps in our understanding …

C1QC, VSIG4, and CFD as Potential Peripheral Blood Biomarkers in Atrial Fibrillation‐Related Cardioembolic Stroke

Q Ding, J Xing, F Bai, W Shao, K Hou… - Oxidative Medicine …, 2023 - Wiley Online Library
Atrial fibrillation (AF) is a major risk factor for ischemic stroke. We aimed to identify novel
potential biomarkers with diagnostic value in patients with atrial fibrillation‐related …

Incidence and clinical outcomes of nosocomial infections in patients presenting with STEMI complicated by cardiogenic shock in the United States

O Chehab, RZ Morsi, A Kanj, RJ Rachwan, M Pahuja… - Heart & Lung, 2020 - Elsevier
Objectives This study addresses the incidence, trends, and impact of nosocomial infections
(NI) on the outcomes of patients admitted with ST-segment elevation myocardial infarction …